A new report published by the Urban Institute suggests that CMS’ Oncology Care Model could be substantially improved by incorporating a formal framework for shared decision making between patients and oncologists.
A new report published by the Urban Institute suggests that CMS’ Oncology Care Model (OCM) could be substantially improved by incorporating a formal framework for shared decision making (SDM) between patients and oncologists.
The report, funded by the Robert Wood Johnson Foundation, explores the history of the OCM, a 5-year pilot program that began in 2016 and aims to shift away from a strictly fee-for-service model towards a value-based paradigm of providing cancer care. The authors explain that the principles and guidelines that gave rise to the OCM’s creation recommend SDM efforts, but CMS did not require such processes when it released the final rule. They argue that amending the policy to incorporate SDM principles could improve the patient experience and potentially avoid inappropriate treatments at the end of life (EOL).
According to the report, the OCM was deemed a patient-centered care model by CMS when it was launched because it incorporated elements like care coordination and emotional support services. Practices are required to discuss treatment goals with patients, but are not obligated to follow a formal SDM framework beyond these discussions.
Support for SDM can be traced back to at least 1999, when the Institutes of Medicine (IOM) said patient preferences were “central to high quality cancer care.” Subsequent IOM publications, including the 2013 report that served as a foundation for the OCM’s development, continued to emphasize the need for SDM and patient-centered communication. CMS indicated when it invited oncology practices to participate in the OCM that the model would require SDM to inform treatment recommendations, but the actual program did not include that mandate when it went into effect in 2016.
To highlight the need for SDM, the Urban Institute report cited several studies that indicated cancer patients may not have the knowledge and opportunities to make decisions about their care. For instance, only 1 in 6 patients with metastatic cancers were able to correctly describe their prognosis, which may have been why many of them had undergone aggressive treatments like chemotherapy near EOL. Proper incorporation of SDM “could guard against chemotherapy overuse or underuse” and “also may address social disparities” by allowing patients to take a more empowered role in their experience with cancer.
From a policy perspective, the report authors argued that SDM is key to achieving value-based cancer care by improving patient satisfaction, even though there is not yet sufficient evidence to demonstrate that eliminating overuse of services through this framework results in cost savings.
“These findings underscore an important distinction between moral values, which concern patient autonomy and peace of mind, and economic value, which concerns dollars and cents,” they wrote.
They explained that the OCM mainly focuses on the economic components of value, but CMS has shown support for incorporating SDM in other initiatives. For instance, the Shared Decision Making Model will assess the impact of a SDM process on outcomes, spending, and patient satisfaction in accountable care organizations.
As such, the authors recommended that SDM should be incorporated into the OCM for certain cancers or at certain practices before the model ends in 2021. They noted that SDM could bring the OCM into alignment with the patient-centered values prominent in other CMS and HHS policies and documents.
“A large body of research indicates that many of the 1.7 million Americans diagnosed with cancer every year would greatly value more information-rich conversations with their doctors,” the report concluded. “Whether or not that desire for greater control over life-and-death decisions saves money for third-party payers, the implementation of shared decision-making shouldn’t require a moonshot-level effort.”
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
Uniting to Support Patients With Cancer Beyond Treatment
November 17th 2024Kasey Bond, MPH, of Perlmutter Cancer Center at NYU Langone Health, speaks to why it’s vital to keep patients at the center of all strategic partnerships between academic institutions and community-based oncology practices.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Bridging Cancer Care Gaps and Overcoming Medical Mistrust
November 13th 2024In this clip from our interview with Oscar B. Lahoud, MD, cochair of our Institute for Value-Based Medicine® evening hosted with NYU Langone Health, he addressed medical mistrust in underrepresented communities.
Read More
How English- and Spanish-Preferring Patients With Cancer Decide on Emergency Care
November 13th 2024Care delivery innovations to help patients with cancer avoid emergency department visits are underused. The authors interviewed English- and Spanish-preferring patients at 2 diverse health systems to understand why.
Read More
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
Uniting to Support Patients With Cancer Beyond Treatment
November 17th 2024Kasey Bond, MPH, of Perlmutter Cancer Center at NYU Langone Health, speaks to why it’s vital to keep patients at the center of all strategic partnerships between academic institutions and community-based oncology practices.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Bridging Cancer Care Gaps and Overcoming Medical Mistrust
November 13th 2024In this clip from our interview with Oscar B. Lahoud, MD, cochair of our Institute for Value-Based Medicine® evening hosted with NYU Langone Health, he addressed medical mistrust in underrepresented communities.
Read More
How English- and Spanish-Preferring Patients With Cancer Decide on Emergency Care
November 13th 2024Care delivery innovations to help patients with cancer avoid emergency department visits are underused. The authors interviewed English- and Spanish-preferring patients at 2 diverse health systems to understand why.
Read More
2 Commerce Drive
Cranbury, NJ 08512